Literature DB >> 1775838

Use of ciprofloxacin for successful eradication of bacteremia due to Campylobacter cinaedi in a human immunodeficiency virus-infected person.

L V Sacks1, A M Labriola, V J Gill, F M Gordin.   

Abstract

A 36-year-old homosexual man who was infected with human immunodeficiency virus presented with a 2-month history of fever and intermittent diarrhea. Stool cultures were negative for bacterial pathogens, ova, parasites, and acid-fast organisms. An initial blood culture became positive after 5 days for a curved, gram-negative rod that was identified later as Campylobacter cinaedi. The patient received a series of antibiotic regimens, including a 2-week course of erythromycin followed by a 2-week course of tetracycline, but follow-up blood cultures continued to yield C. cinaedi. The patient was then treated with a 2-week course of oral ciprofloxacin; he remained asymptomatic 11 weeks later, at which time a blood culture was negative for C. cinaedi. To the best of our knowledge, this is the first documented case of symptomatic bacteremia due to C. cinaedi that was successfully treated with ciprofloxacin.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1775838     DOI: 10.1093/clinids/13.6.1066

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  11 in total

Review 1.  Non-pylori Helicobacter species in humans.

Authors:  J L O'Rourke; M Grehan; A Lee
Journal:  Gut       Date:  2001-11       Impact factor: 23.059

2.  Molecular epidemiologic analysis and antimicrobial resistance of Helicobacter cinaedi isolated from seven hospitals in Japan.

Authors:  Emiko Rimbara; Shigetarou Mori; Mari Matsui; Satowa Suzuki; Jun-Ichi Wachino; Yoshiaki Kawamura; Zeli Shen; James G Fox; Keigo Shibayama
Journal:  J Clin Microbiol       Date:  2012-05-16       Impact factor: 5.948

3.  Simultaneous identification of campylobacters and prediction of quinolone resistance by comparative sequence analysis.

Authors:  M Husmann; A Feddersen; A Steitz; C Freytag; S Bhakdi
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

4.  Captive rhesus monkeys (Macaca mulatta) are commonly infected with Helicobacter cinaedi.

Authors:  Kathy R Fernandez; Lori M Hansen; Peter Vandamme; Blaine L Beaman; Jay V Solnick
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

Review 5.  The non-H pylori helicobacters: their expanding role in gastrointestinal and systemic diseases.

Authors:  J G Fox
Journal:  Gut       Date:  2002-02       Impact factor: 23.059

Review 6.  Emergence of diverse Helicobacter species in the pathogenesis of gastric and enterohepatic diseases.

Authors:  J V Solnick; D B Schauer
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

7.  Helicobacter cinaedi cellulitis and bacteremia in immunocompetent hosts after orthopedic surgery.

Authors:  Toshio Kitamura; Yoshiaki Kawamura; Kiyofumi Ohkusu; Takayuki Masaki; Hirofumi Iwashita; Tomohiro Sawa; Shigemoto Fujii; Tatsuya Okamoto; Takaaki Akaike
Journal:  J Clin Microbiol       Date:  2006-11-01       Impact factor: 5.948

8.  Epithelial Coculture and l-Lactate Promote Growth of Helicobacter cinaedi under H2-Free Aerobic Conditions.

Authors:  Jonathan E Schmitz; Takako Taniguchi; Naoaki Misawa; Timothy L Cover
Journal:  Appl Environ Microbiol       Date:  2016-10-27       Impact factor: 4.792

9.  Genotypic and phenotypic characterization of Helicobacter cinaedi and Helicobacter fennelliae strains isolated from humans and animals.

Authors:  J A Kiehlbauch; D J Brenner; D N Cameron; A G Steigerwalt; J M Makowski; C N Baker; C M Patton; I K Wachsmuth
Journal:  J Clin Microbiol       Date:  1995-11       Impact factor: 5.948

Review 10.  Recurrent bacteremia with Helicobacter cinaedi: case report and review of the literature.

Authors:  Ilker Uçkay; Jorge Garbino; Pierre-Yves Dietrich; Béatrice Ninet; Peter Rohner; Véronique Jacomo
Journal:  BMC Infect Dis       Date:  2006-05-23       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.